Lineage Cell Therapeutics, Inc. · AMEX:LCTX

Mulroy Michael H. bought 30,000 Lineage Cell Therapeutics, Inc. shares (Form 4)

Traded Nov 17, 2026 · Filed Nov 19, 2026

On Nov 17, 2026, Mulroy Michael H. (Director) bought 30,000 Lineage Cell Therapeutics, Inc. shares at US$0.87 for US$26,100, leaving 328,555 shares. Filed Nov 19, 2026 (Form 4).

Bought
30,000 shares
Price
US$0.87
Value
US$26,100
Holding after
328,555 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 17, 2026Common SharesBuy30,000US$0.87328,555Direct

Source

Download original · View original at SEC

Related